GTN Company
GTN innovates a quantum machine learning technology to transform drug discovery.
Technology:
Small Molecules
Industry:
AI in Pharma
Headquarters:
London, England, United Kingdom
Founded Date:
2017
Employees Number:
1-10
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Register and Claim Ownership